Directional Asset Management Takes Position in Option Care Health, Inc. $OPCH

Key Points

• Directional Asset Management bought 314,450 shares of Option Care Health in Q4 (≈$10.02M), making OPCH its largest holding at 8.8% and representing 0.20% of the company’s shares.
• Option Care Health reported Q4 EPS of $0.46 (in line with estimates) and revenue of $1.47B, up 8.8% year-over-year, with a return on equity of 18.57% and a net margin of 3.67%.
• The stock has a market cap of $4.48B and a P/E of 22.30, with institutional ownership at 98.05% and an average analyst rating of “Moderate Buy” with an average target price of $37.27.

Directional Asset Management acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 314,450 shares of the company's stock, valued at approximately $10,018,000. Option Care Health makes up 8.8% of Directional Asset Management's holdings, making the stock its largest holding. Directional Asset Management owned 0.20% of Option Care Health as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Swedbank AB purchased a new stake in shares of Option Care Health in the 3rd quarter valued at about $49,455,000. Pacer Advisors Inc. purchased a new position in shares of Option Care Health during the third quarter worth about $593,000. Victory Capital Management Inc. grew its holdings in shares of Option Care Health by 129.5% during the third quarter. Victory Capital Management Inc. now owns 383,605 shares of the company's stock worth $10,649,000 after purchasing an additional 216,489 shares in the last quarter. Geneva Capital Management LLC increased its position in shares of Option Care Health by 27.6% in the third quarter. Geneva Capital Management LLC now owns 1,369,862 shares of the company's stock worth $38,027,000 after purchasing an additional 296,216 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA increased its position in shares of Option Care Health by 2.7% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,244,321 shares of the company's stock worth $34,542,000 after purchasing an additional 33,019 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Option Care Health Stock Up 0.6%

Shares of NASDAQ:OPCH opened at $28.54 on Friday. The stock has a market capitalization of $4.48 billion, a P/E ratio of 22.30, a price-to-earnings-growth ratio of 1.59 and a beta of 0.95. The stock's 50-day moving average price is $30.07 and its 200-day moving average price is $30.72. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 0.87. Option Care Health, Inc. has a 12-month low of $24.24 and a 12-month high of $36.80.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a return on equity of 18.57% and a net margin of 3.67%.Option Care Health's revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.44 EPS. On average, equities analysts anticipate that Option Care Health, Inc. will post 1.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several research analyst reports. TD Cowen reiterated a "hold" rating on shares of Option Care Health in a research report on Tuesday, January 27th. Weiss Ratings reissued a "hold (c)" rating on shares of Option Care Health in a report on Monday, December 29th. Citizens Jmp restated a "market outperform" rating and set a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research report on Tuesday, January 13th. Wall Street Zen downgraded shares of Option Care Health from a "buy" rating to a "hold" rating in a report on Saturday, February 28th. Finally, Truist Financial set a $40.00 target price on shares of Option Care Health in a research report on Tuesday, January 13th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $37.27.

About Option Care Health

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.